263 related articles for article (PubMed ID: 23257358)
1. Direct control of hepatic glucose production by interleukin-13 in mice.
Stanya KJ; Jacobi D; Liu S; Bhargava P; Dai L; Gangl MR; Inouye K; Barlow JL; Ji Y; Mizgerd JP; Qi L; Shi H; McKenzie AN; Lee CH
J Clin Invest; 2013 Jan; 123(1):261-71. PubMed ID: 23257358
[TBL] [Abstract][Full Text] [Related]
2. T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis.
Fukushima A; Loh K; Galic S; Fam B; Shields B; Wiede F; Tremblay ML; Watt MJ; Andrikopoulos S; Tiganis T
Diabetes; 2010 Aug; 59(8):1906-14. PubMed ID: 20484139
[TBL] [Abstract][Full Text] [Related]
3. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
5. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.
Inoue H; Ogawa W; Asakawa A; Okamoto Y; Nishizawa A; Matsumoto M; Teshigawara K; Matsuki Y; Watanabe E; Hiramatsu R; Notohara K; Katayose K; Okamura H; Kahn CR; Noda T; Takeda K; Akira S; Inui A; Kasuga M
Cell Metab; 2006 Apr; 3(4):267-75. PubMed ID: 16581004
[TBL] [Abstract][Full Text] [Related]
6. Molecular signaling mechanisms of renal gluconeogenesis in nondiabetic and diabetic conditions.
Swe MT; Pongchaidecha A; Chatsudthipong V; Chattipakorn N; Lungkaphin A
J Cell Physiol; 2019 Jun; 234(6):8134-8151. PubMed ID: 30370538
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
8. CYT387, a Novel JAK2 Inhibitor, Suppresses IL-13-Induced Epidermal Barrier Dysfunction Via miR-143 Targeting IL-13Rα1 and STAT3.
Zu Y; Chen XF; Li Q; Zhang ST
Biochem Genet; 2021 Apr; 59(2):531-546. PubMed ID: 33190168
[TBL] [Abstract][Full Text] [Related]
9. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance.
Priceman SJ; Kujawski M; Shen S; Cherryholmes GA; Lee H; Zhang C; Kruper L; Mortimer J; Jove R; Riggs AD; Yu H
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13079-84. PubMed ID: 23878227
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-13 drives metabolic conditioning of muscle to endurance exercise.
Knudsen NH; Stanya KJ; Hyde AL; Chalom MM; Alexander RK; Liou YH; Starost KA; Gangl MR; Jacobi D; Liu S; Sopariwala DH; Fonseca-Pereira D; Li J; Hu FB; Garrett WS; Narkar VA; Ortlund EA; Kim JH; Paton CM; Cooper JA; Lee CH
Science; 2020 May; 368(6490):. PubMed ID: 32355002
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
Yan H; Yang W; Zhou F; Li X; Pan Q; Shen Z; Han G; Newell-Fugate A; Tian Y; Majeti R; Liu W; Xu Y; Wu C; Allred K; Allred C; Sun Y; Guo S
Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265
[TBL] [Abstract][Full Text] [Related]
13. The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4.
Sheikh F; Dickensheets H; Pedras-Vasconcelos J; Ramalingam T; Helming L; Gordon S; Donnelly RP
J Innate Immun; 2015; 7(5):494-505. PubMed ID: 25766112
[TBL] [Abstract][Full Text] [Related]
14. Silencing of FGF-21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3-SOCS3 signal.
Wang C; Dai J; Yang M; Deng G; Xu S; Jia Y; Boden G; Ma ZA; Yang G; Li L
FEBS J; 2014 May; 281(9):2136-47. PubMed ID: 24593051
[TBL] [Abstract][Full Text] [Related]
15. Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1-driven gluconeogenesis.
Liu N; Yang X; Guo J; Zhang L; Huang S; Chen J; Huang J; Chen Y; Cui T; Zheng Y; Li T; Tang K; Zhong Y; Duan S; Yu L; Tang Y; Zheng D; Pan H; Gao Y
EMBO Rep; 2023 Jun; 24(6):e56390. PubMed ID: 37154299
[TBL] [Abstract][Full Text] [Related]
16. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice.
Ge W; Zhao Y; Yang Y; Ding Z; Xu X; Weng D; Wang S; Cheng R; Zhang J
J Biol Chem; 2021 Jul; 297(1):100846. PubMed ID: 34058194
[TBL] [Abstract][Full Text] [Related]
17. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
Chen Z; Sheng L; Shen H; Zhao Y; Wang S; Brink R; Rui L
Diabetes; 2012 Mar; 61(3):566-73. PubMed ID: 22315325
[TBL] [Abstract][Full Text] [Related]
18. On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes.
Ukah TK; Cattin-Roy AN; Chen W; Miller MM; Barik S; Zaghouani H
J Immunol; 2017 Aug; 199(3):894-902. PubMed ID: 28646042
[TBL] [Abstract][Full Text] [Related]
19. Developmental expression of IL-12Rβ2 on murine naive neonatal T cells counters the upregulation of IL-13Rα1 on primary Th1 cells and balances immunity in the newborn.
Hoeman CM; Dhakal M; Zaghouani AA; Cascio JA; Wan X; Khairallah MT; Chen W; Zaghouani H
J Immunol; 2013 Jun; 190(12):6155-63. PubMed ID: 23650613
[TBL] [Abstract][Full Text] [Related]
20. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.
Wu C; Khan SA; Peng LJ; Li H; Carmella SG; Lange AJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E536-43. PubMed ID: 16621898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
